奥昔非君
外观
临床资料 | |
---|---|
AHFS/Drugs.com | 国际药品名称 |
ATC码 | |
识别信息 | |
| |
CAS号 | 15687-41-9 |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
化学信息 | |
化学式 | C19H23NO3 |
摩尔质量 | 313.40 g·mol−1 |
3D模型(JSmol) | |
| |
|
奥昔非君(INN:oxyfedrine)是一种血管扩张剂[1]和β肾上腺素受体激动剂。[2][3]
研究发现,它可以抑制冠状血管的张力,[4]改善心肌代谢(使心脏更好地撑过缺氧),并发挥正变时和正性肌力作用,从而避免诱发心绞痛。[4][5]正性变时性和正性肌力作用尤其重要,因为用于心绞痛的其他血管扩张剂可能会适得其反,导致冠状动脉窃血现象。[6]
有研究提出奥昔非君可与抗生素产生协同作用。[7]
合成
[编辑]参考资料
[编辑]- ^ Otsuki, Yuji; Yamasaki, Juntaro; Suina, Kentaro; Okazaki, Shogo; Koike, Naoyoshi; Saya, Hideyuki; Nagano, Osamu. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy. Cancer Science. 2020-01, 111 (1) [2024-05-09]. ISSN 1349-7006. PMC 6942438 . PMID 31692172. doi:10.1111/cas.14224. (原始内容存档于2024-05-09).
- ^ Sakai, Kazushige; Shiraki, Yasuyuki; Hashimoto, Koroku. An analysis of the ß-adrenergic action of oxyfedrine. European Journal of Pharmacology. 1973-01-01, 21 (1). ISSN 0014-2999. doi:10.1016/0014-2999(73)90210-0.
- ^ Beckett, P. R.; Foster, R. W. Oxyfedrine — A partial agonist at β-adrenoceptors. European Journal of Pharmacology. 1972-11-01, 20 (2). ISSN 0014-2999. doi:10.1016/0014-2999(72)90145-8.
- ^ 4.0 4.1 Chichkanov, G. G.; Chumburidze, V. B. [Mechanism of the antianginal action of oxyfedrine]. Farmakologiia I Toksikologiia. 1977, 40 (3) [2024-05-09]. ISSN 0014-8318. PMID 20326. (原始内容存档于2024-06-14).
- ^ Jc, Kaski; L, Araujo; A, Maseri. Effects of oxyfedrine on regional myocardial blood flow in patients with coronary artery disease. Cardiovascular drugs and therapy. 1991 Dec, 5 (6) [2024-05-09]. ISSN 0920-3206. PMID 1801897. doi:10.1007/BF00143526. (原始内容存档于2024-05-09) (英语).
- ^ Chichkanov, G. G.; Bogolepov, A. K.; Matsievskiĭ, D. D. [Mechanism of the effect of anti-angina drugs with adrenergic beta receptor agonist action on the collateral hemodynamics and redistribution of the blood flow in chronic myocardial ischemia]. Kardiologiia. 1981-10, 21 (10). ISSN 0022-9040. PMID 6117671.
- ^ Mazumdar K, Dutta NK, Kumar KA, Dastidar SG. In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains. Biological & Pharmaceutical Bulletin. April 2005, 28 (4): 713–7 [2024-05-09]. PMID 15802815. doi:10.1248/bpb.28.713 . (原始内容存档于2024-06-06).
- ^ Thiele Kurt, 美国专利第3,225,095号 (1965 to Degussa).